The major conclusion from the present study is that human pancreatic cancer cells undergo profound metabolic reprogramming that drives the acquisition of stem cell-like properties at different degrees after adaptation to silencing of AKT isoforms. This evidence concerns the gene AKT1 and pancreatic neoplasm.